Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Autosomal dominant polycystic kidney disease: prevalence of renal neoplasias in surgical kidney specimens.

Jilg CA, Drendel V, Bacher J, Pisarski P, Neeff H, Drognitz O, Schwardt M, Gläsker S, Malinoc A, Erlic Z, Nunez M, Weber A, Azurmendi P, Schultze-Seemann W, Werner M, Neumann HP.

Nephron Clin Pract. 2013;123(1-2):13-21. doi: 10.1159/000351049. Epub 2013 Jun 4.

PMID:
23752029
2.

Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure.

Hajj P, Ferlicot S, Massoud W, Awad A, Hammoudi Y, Charpentier B, Durrbach A, Droupy S, Benoît G.

Urology. 2009 Sep;74(3):631-4. doi: 10.1016/j.urology.2009.02.078. Epub 2009 Jul 18.

PMID:
19616833
3.

Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?

Gigante M, Neuzillet Y, Patard JJ, Tillou X, Thuret R, Branchereau J, Timsit MO, Terrier N, Boutin JM, Sallusto F, Karam G, Barrou B, Chevallier D, Mazzola CR, Delaporte V, Doeffler A, Kleinclauss F, Badet L; members of the Comité de Cancerologie de l'Association Française d'Urologie (CCAFU); Comité de Transplantation de l'Association Française d'Urologie (CTAFU).

BJU Int. 2012 Dec;110(11 Pt B):E570-3. doi: 10.1111/j.1464-410X.2012.11273.x. Epub 2012 Jun 22.

4.

Bilateral papillary renal cell carcinoma and angiomyolipoma in the patients with autosomal dominant polycystic kidney disease: case report of two cases and literature review.

Konosu-Fukaya S, Nakamura Y, Fujishima F, Kasajima A, Takahashi Y, Joh K, Ikeda Y, Ioritani N, Watanabe M, Sasano H.

Pol J Pathol. 2013 Dec;64(4):303-7. Review.

5.

Renal cell carcinoma co-existent with other renal disease: clinico-pathological features in pre-dialysis patients and those receiving dialysis or renal transplantation.

Peces R, Martínez-Ara J, Miguel JL, Arrieta J, Costero O, Górriz JL, Picazo ML, Fresno M.

Nephrol Dial Transplant. 2004 Nov;19(11):2789-96. Epub 2004 Aug 17.

PMID:
15316098
6.

Bilateral renal cell carcinoma in a patient with autosomal dominant polycystic kidney disease.

Chang YL, Chung HJ, Chen KK.

J Chin Med Assoc. 2007 Sep;70(9):403-5.

7.

Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease.

Patel P, Horsfield C, Compton F, Taylor J, Koffman G, Olsburgh J.

Ann R Coll Surg Engl. 2011 Jul;93(5):391-5. doi: 10.1308/003588411X582690.

8.

A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.

Zeltner R, Hilgers KF, Schmieder RE, Porst M, Schulze BD, Hartner A.

Nephron Clin Pract. 2008;108(3):c169-75. doi: 10.1159/000116887. Epub 2008 Feb 14.

PMID:
18277079
9.

[Co-inheritance of autosomal dominant polycystic kidney disease and sickle cell trait in African Americans].

Peces R, Peces C, Cuesta-López E, Vega-Cabrera C, Azorín S, Pérez-Dueñas V, Selgas R.

Nefrologia. 2011;31(2):162-8. doi: 10.3265/Nefrologia.pre2010.Dec.10660. Spanish.

10.

Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan.

Higashihara E, Nutahara K, Kojima M, Tamakoshi A, Yoshiyuki O, Sakai H, Kurokawa K.

Nephron. 1998 Dec;80(4):421-7.

PMID:
9832641
11.

[Epidemiological and molecular study of autosomal dominant polycystic kidney disease (ADPKD) in the province of Vicenza, Italy: possible founder effect?].

Corradi V, Gastaldon F, Virzi' GM, Clementi M, Nalesso F, Cruz DN, de Cal M, Torregrossa R, Ronco C.

G Ital Nefrol. 2010 Nov-Dec;27(6):655-63. Italian.

PMID:
21132648
12.

Renal cell carcinoma of native kidney in Chinese renal transplant recipients: a report of 12 cases and a review of the literature.

Cheung CY, Lam MF, Lee KC, Chan GS, Chan KW, Chau KF, Li CS, Chan TM, Lai KN.

Int Urol Nephrol. 2011 Sep;43(3):675-80. doi: 10.1007/s11255-011-9912-2. Epub 2011 Mar 10. Review.

13.

Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.

Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB.

Am J Surg Pathol. 2006 Feb;30(2):141-53.

PMID:
16434887
14.

Renal cell carcinoma in dialysis patients: a single center experience.

Kojima Y, Takahara S, Miyake O, Nonomura N, Morimoto A, Mori H.

Int J Urol. 2006 Aug;13(8):1045-8.

15.

Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques.

Mosetti MA, Leonardou P, Motohara T, Kanematsu M, Armao D, Semelka RC.

J Magn Reson Imaging. 2003 Aug;18(2):210-5.

PMID:
12884334
16.

Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group.

Christophe JL, van Ypersele de Strihou C, Pirson Y.

Nephrol Dial Transplant. 1996 Jul;11(7):1271-6.

PMID:
8672022
17.

Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis.

Nouh MA, Kuroda N, Yamashita M, Hayashida Y, Yano T, Minakuchi J, Taniguchi S, Nomura I, Inui M, Sugimoto M, Kakehi Y.

BJU Int. 2010 Mar;105(5):620-7. doi: 10.1111/j.1464-410X.2009.08817.x. Epub 2009 Aug 28.

18.

Frequency and clinical profile of patients with polycystic kidney disease in southern Brazil.

Nunes AC, Milani V, Porsch DB, Rossato LB, Mattos CB, Roisenberg I, Barros EJ.

Ren Fail. 2008;30(2):169-73. doi: 10.1080/08860220701810265.

PMID:
18300116
19.

Risk of intracranial hemorrhage associated with autosomal dominant polycystic kidney disease in patients with end stage renal disease.

Yoo DJ, Agodoa L, Yuan CM, Abbott KC, Nee R.

BMC Nephrol. 2014 Feb 26;15:39. doi: 10.1186/1471-2369-15-39.

20.

Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis.

Satoh S, Tsuchiya N, Habuchi T, Ishiyama T, Seimo K, Kato T.

J Urol. 2005 Nov;174(5):1749-53.

PMID:
16217276

Supplemental Content

Support Center